Joshua R. Disbrow's most recent trade in Aytu BioPharma Inc was a trade of 66,666 Common Stock done at an average price of $1.5 . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aytu BioPharma Inc | Joshua R. Disbrow | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 09 Jun 2025 | 66,666 | 153,257 (0%) | 0% | 1.5 | 99,999 | Common Stock |
| Zynex Inc | Joshua R. Disbrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 10,000 | 22,500 | - | 0 | Common Stock (Restricted Stock Award) | |
| Aytu BioPharma Inc | Joshua R. Disbrow | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 28 Feb 2025 | 15,000 | 86,591 (0%) | 0% | 1.3 | 19,500 | Common Stock |
| Aytu BioPharma Inc | Joshua R. Disbrow | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 38,000 | 38,000 | - | - | Employee Stock Option (Right to Buy) | |
| Zynex Inc | Joshua R. Disbrow | Director | Purchase of securities on an exchange or from another person at price $ 8.32 per share. | 29 Jul 2024 | 7,000 | 72,000 (0%) | 0% | 8.3 | 58,233 | Common Stock |
| Zynex Inc | Joshua R. Disbrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 10,000 | 22,587 | - | 0 | Common Stock (Restricted Stock Award) | |
| Aytu BioPharma Inc | Joshua R. Disbrow | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 35,000 | 35,000 | - | - | Employee Stock Option (Right to Buy) | |
| Zynex Inc | Joshua R. Disbrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 22,171 (0%) | 0% | 0 | Common Stock (Restricted Stock Award) | |
| Aytu BioPharma Inc | Joshua R. Disbrow | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.86 per share. | 14 Jun 2023 | 14,000 | 71,591 (0%) | 0% | 1.9 | 26,079 | Common Shares |
| Aytu BioPharma Inc | Joshua R. Disbrow | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.22 per share. | 19 Dec 2022 | 112,371 | 1,231,877 (4%) | 0% | 0.2 | 25,047 | Common Stock |
| Aytu BioPharma Inc | Joshua R. Disbrow | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.24 per share. | 18 Nov 2022 | 222,000 | 1,119,506 (3%) | 0% | 0.2 | 52,614 | Common Shares |
| Zynex Inc | Joshua R. Disbrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 10,000 | 24,208 (0%) | 0% | 0 | Common Stock (Restricted Stock Award) | |
| Zynex Inc | Joshua R. Disbrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2021 | 10,000 | 23,751 (0%) | 0% | 0 | Common Stock (Restricted Stock Award) | |
| Zynex Inc | Joshua R. Disbrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2020 | 10,000 | 25,000 | - | 0 | Common Stock (Restricted Stock Award) | |
| Zynex Inc | Joshua R. Disbrow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2020 | 10,000 | 15,000 | - | 0 | Common Stock (Restricted Stock Award) |